Title |
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer
|
---|---|
Published in |
Journal for Immunotherapy of Cancer, September 2019
|
DOI | 10.1186/s40425-019-0733-7 |
Pubmed ID | |
Authors |
Fan Luo, Min Luo, Qi-Xiang Rong, Hong Zhang, Zhen Chen, Fang Wang, Hong-Yun Zhao, Li-Wu Fu |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 45% |
Canada | 1 | 9% |
Spain | 1 | 9% |
India | 1 | 9% |
Unknown | 3 | 27% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 36% |
Science communicators (journalists, bloggers, editors) | 3 | 27% |
Scientists | 2 | 18% |
Practitioners (doctors, other healthcare professionals) | 2 | 18% |
Mendeley readers
The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 53 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 11% |
Researcher | 6 | 11% |
Student > Bachelor | 5 | 9% |
Student > Master | 5 | 9% |
Other | 3 | 6% |
Other | 7 | 13% |
Unknown | 21 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 11 | 21% |
Medicine and Dentistry | 10 | 19% |
Agricultural and Biological Sciences | 3 | 6% |
Unspecified | 2 | 4% |
Immunology and Microbiology | 2 | 4% |
Other | 2 | 4% |
Unknown | 23 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2022.
All research outputs
#6,808,536
of 25,540,105 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,618
of 3,454 outputs
Outputs of similar age
#111,717
of 351,891 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#45
of 79 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 3,454 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,891 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.